Advertisement News Archives - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

March 22, 2019

Conatus announces top-line results from ENCORE-NF phase 2b clinical trial in NASH fibrosis

Conatus Pharmaceuticals has announced top-line results from the company’s Phase 2b ENCORE-NF clinical trial in patients with biopsy-confirmed nonalcoholic steatohepatitis (NASH) and liver fibrosis.

Conatus announces top-line results from ENCORE-NF phase 2b clinical trial in NASH fibrosis